{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:02:45Z","timestamp":1761058965896},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2288,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/ki.2009.223","type":"journal-article","created":{"date-parts":[[2009,6,17]],"date-time":"2009-06-17T19:25:02Z","timestamp":1245266702000},"page":"599-603","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Alport syndrome: beyond animal models"],"prefix":"10.1016","volume":"76","author":[{"given":"Oliver","family":"Gross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford E.","family":"Kashtan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.223_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJMra022296","article-title":"Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.223_bb0015","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00063-005-1114-1","article-title":"From the molecular genetics of Alport\u2019s syndrome to principles of organo-protection in chronic renal diseases","volume":"100","author":"Gross","year":"2005","journal-title":"Med Klin"},{"key":"10.1038\/ki.2009.223_bb0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.223_bb0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.223_bb0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/humu.9349","article-title":"Novel COL4A5, COL4A4 and COL4A3 mutations in Alport syndrome","volume":"26","author":"Nagel Nagel","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1038\/ki.2009.223_bb0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.ki.5002115","article-title":"Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis","volume":"71","author":"Cosgrove","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.223_bb0040","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF00868709","article-title":"Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study","volume":"9","author":"Kashtan","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2009.223_bb0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ndt\/gfn722","article-title":"Stem cell therapy for Alport syndrome: the hope beyond the hype","volume":"24","author":"Gross","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.223_bb0050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9440(10)64892-4","article-title":"Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome","volume":"160","author":"Andrews","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2009.223_bb0055","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/ndt\/gfh219","article-title":"Antifibrotic, nephroprotective potential of ACE-inhibitor vs AT1 antagonist in a murine model of renal fibrosis","volume":"19","author":"Gross","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.223_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9975(97)80016-3","article-title":"Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor","volume":"117","author":"Grodecki","year":"1997","journal-title":"J Comp Pathol"},{"key":"10.1038\/ki.2009.223_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0272-6386(96)90540-5","article-title":"In hereditary nephritis angiotensin-converting enzyme inhibition decreases proteinuria and may slow the rate of progression","volume":"27","author":"Cohen","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.223_bb0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s004310051301","article-title":"Enalapril in paediatric patients with Alport syndrome: 2 years\u2019 experience","volume":"159","author":"Proesmans","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1038\/ki.2009.223_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00467-003-1366-z","article-title":"Enalapril in children with Alport syndrome","volume":"19","author":"Proesmans","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2009.223_bb0080","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00467-006-0270-8","article-title":"The effect of aldosterone blockade in patients with Alport syndrome","volume":"21","author":"Kaito","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2009.223_bb0085","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.ASN.0000046964.15831.16","article-title":"Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.223_bb0090","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1523-1755.1999.0550031051.x","article-title":"Long-term effects of cyclosporine A in Alport\u2019s syndrome","volume":"55","author":"Callis","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.223_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00467-006-0227-y","article-title":"Cyclosporin therapy in patients with Alport syndrome","volume":"22","author":"Charbit","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2009.223_bb0100","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0002-9440(10)64802-X","article-title":"Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy","volume":"157","author":"Cosgrove","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2009.223_bb0105","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pmed.0030100","article-title":"Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease","volume":"3","author":"Zeisberg","year":"2006","journal-title":"PLoS Med"},{"key":"10.1038\/ki.2009.223_bb0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1523-1755.2005.00423.x","article-title":"Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688","volume":"68","author":"Gross","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.223_bb0115","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1681\/ASN.2004100871","article-title":"Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease","volume":"16","author":"Ninichuk","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.223_bb0120","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/ndt\/gfl810","article-title":"Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome","volume":"22","author":"Koepke","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.223_bb0125","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/ki.2009.223_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000020641","article-title":"Animal models of Alport syndrome: advancing the prospects for effective human gene therapy","volume":"8","author":"Heikkil\u00e4","year":"2000","journal-title":"Exp Nephrol"},{"key":"10.1038\/ki.2009.223_bb0135","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1634\/stemcells.2006-0201","article-title":"Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome","volume":"24","author":"Prodromidi","year":"2006","journal-title":"Stem Cells"},{"key":"10.1038\/ki.2009.223_bb0140","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1073\/pnas.0601436103","article-title":"Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease","volume":"103","author":"Sugimoto","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.223_bb0145","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1681\/ASN.2007070829","article-title":"Irradiation prolongs survival of Alport mice","volume":"19","author":"Katayama","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.223_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.ki.5001521","article-title":"Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice","volume":"70","author":"Ninichuk","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.223_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000151314","article-title":"X chromosome inactivation patterns in normal and X-linked hereditary nephropathy carrier dogs","volume":"122","author":"Bell","year":"2008","journal-title":"Cytogenet Genome Res"},{"key":"10.1038\/ki.2009.223_bb0160","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/ndt\/gfm024","article-title":"Alport syndrome and the x chromosome: implications of a diagnosis of Alport syndrome in females","volume":"22","author":"Kashtan","year":"2007","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815540258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T14:14:41Z","timestamp":1633616081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815540258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0085253815540258"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.223","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}